CTOs on the Move

Accure Acne

www.accureacne.com

 
At Accure, we are wholly committed to developing revolutionary solutions to provide a long-lasting, durable response to acne. We know that acne can have a devastating social, psychological, physical, and economic impact on patients around the world. We are pioneering transformative solutions that will answer this unmet need and have a positive and profound impact on patients and providers worldwide.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.accureacne.com
  • 4699 Nautilus Court South Suite 205
    Boulder, CO USA 80301
  • Phone: 303.886.6125

Executives

Name Title Contact Details
Alfred Intintoli
Chief Technology Officer Profile

Funding

Accure Acne raised $20M on 04/22/2021

Similar Companies

A Plus Intl

A Plus Intl is a Chino, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Becon Medical

Becon Medical is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CIMIT -Center for integration of medicine and innovative technology

CIMIT -Center for integration of medicine and innovative technology is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nucletron

Nucletron Corp. is a Columbia, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IlluminOss

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, IlluminOss System. This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The IlluminOss System utilizes a light-curable polymer, contained within an expandable balloon catheter to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-specific, method of orthopedic bone stabilization. The company currently markets its products in the EU under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Flare Capital Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology.